Mitsubishi UFJ Asset Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.3M | Buy |
312,743
+1,154
| +0.4% | +$41.6K | 0.01% | 564 |
|
|
2025
Q1 | $9.7M | Buy |
311,589
+55,400
| +22% | +$1.72M | 0.01% | 579 |
|
|
2024
Q4 | $6.62M | Buy |
256,189
+835
| +0.3% | +$21.6K | 0.01% | 621 |
|
|
2024
Q3 | $7.22M | Buy |
255,354
+38,919
| +18% | +$1.1M | 0.01% | 600 |
|
|
2024
Q2 | $5.71M | Hold |
216,435
| – | – | 0.01% | 623 |
|
|
2024
Q1 | $6.57M | Buy |
216,435
+29,672
| +16% | +$901K | 0.01% | 590 |
|
|
2023
Q4 | $5.18M | Buy |
186,763
+1,223
| +0.7% | +$33.9K | 0.01% | 598 |
|
|
2023
Q3 | $5.04M | Buy |
185,540
+23,110
| +14% | +$627K | 0.01% | 589 |
|
|
2023
Q2 | $4.99M | Buy |
162,430
+43,118
| +36% | +$1.33M | 0.01% | 588 |
|
|
2023
Q1 | $4.3M | Buy |
119,312
+12,128
| +11% | +$437K | 0.01% | 597 |
|
|
2022
Q4 | $4.22M | Buy |
107,184
+8,800
| +9% | +$347K | 0.01% | 583 |
|
|
2022
Q3 | $3.95M | Buy |
98,384
+8,100
| +9% | +$325K | 0.01% | 586 |
|
|
2022
Q2 | $3.8M | Buy |
90,284
+8,700
| +11% | +$366K | 0.02% | 591 |
|
|
2022
Q1 | $3.18M | Sell |
81,584
-1,452
| -2% | -$56.6K | 0.01% | 648 |
|
|
2021
Q4 | $3.26M | Buy |
83,036
+38,800
| +88% | +$1.52M | 0.01% | 669 |
|
|
2021
Q3 | $1.6M | Buy |
44,236
+7,900
| +22% | +$286K | 0.01% | 769 |
|
|
2021
Q2 | $1.49M | Sell |
36,336
-277
| -0.8% | -$11.4K | 0.01% | 792 |
|
|
2021
Q1 | $1.6M | Buy |
36,613
+14,949
| +69% | +$652K | 0.01% | 738 |
|
|
2020
Q4 | $1.08M | Buy |
+21,664
| New | +$1.08M | 0.01% | 749 |
|